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CHAPTER I
INTRODUCTION
Surgery as the modality of treatment for jaundice is not fully acceptable to a large majority of 
population in our part of the country. May be because of high belief in ayurvedic medicine, 
which is accepted as the best remedy for jaundice, and probably due to lower incidence of 
obstructive jaundice in our population in the past. Anyhow there is an increasing evidence of 
obstructive  jaundice  especially  malignant  obstructive  jaundice.  Surgeons  thus  face  an 
increasing number of patients  with obstructive jaundice reaching them in a fairly advance 
stage.
The fundamental problem met with in dealing with a patient with prolonged jaundice is the 
accurate diagnosis of its cause whether obstructive or not and if obstructive what exactly its 
cause.
In managing malignant obstructive jaundice the problem of diagnosis becomes an acute one 
because jaundice caused by mechanical obstruction to common bile duct should be surgically 
remedied whereas in the absence of mechanical block of bile duct treatment becomes medical. 
The accurate diagnosis of mechanical obstruction to CBD becomes difficult at times because 
the clinical features and biochemical investigation may be atypical. Intrahepatic cholestasis 
gives rise to clinical features and laboratory data similar to mechanical block of common bile 
duct.  Many  times  hepatocellular  damage  and  mechanical  obstruction  coexist  making  the 
diagnosis much more difficult.
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Treatment of malignant obstructive jaundice is challenging. Surgical treatment ranges from 
definitive surgical procedures to palliative procedures. Non operative management includes 
endoscopic stenting, and interventional radiological procedure like PTBD. All these tests the 
surgeon because of relative inaccessibility of the extrahepatic biliary tree and pancreas.
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CHAPTER II
REVIEW OF LITERATURE – I 
ANATOMY OF BILIARY TREE
The  biliary  tract  begins  as  a  series  of  blind  ending  channels  or  canaliculi  formed  by 
specialized structures in the cell membrane of adjoining hepatocytes. These canaliculi drain 
into the ductules which initially are single layered epithelial tubes and later a muscular tube 
with inner epithelial lining. These ductules join together to form the interlobar duct emptying 
in the right and left hepatic ducts emerging from each lobe of the liver. These hepatic ducts 
unite to form the common hepatic duct, which receives the cystic duct to become the common 
bile duct. The common bile ducts in most of the cases before entering the duodenum receives 
the pancreatic duct and the two share a final channel for about 7 mm in length within the 
pancreas. Thus the biliary tree has
1. Hepatic component
2. Extrahepatic component
3. Pancreatic component
Defects in the form of blockade anywhere in the hepatobiliary pancreatic system thus results 
in cholestatic jaundice.
GROSS ANATOMY
LIVER
Liver is the largest gland in the body. It is almost completely covered with peritoneum, which 
is reflected on to the adjacent structures forming the so called falciform ligament of the liver. 
The region devoid of peritoneum is the bare area of the liver.
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The liver has got diaphragmatic and visceral surfaces. The diaphragmatic surface has anterior, 
posterior, superior and lateral surface or parts. The bare area of liver comes in the posterior 
surface of the liver. The porta hepatis and the gall bladder are related to the visceral or inferior 
surface.
Grossly the liver is divided into a larger right and a smaller left lobe by the attachment of the 
falciform  ligament  on  the  superior  and  anterior  surface  of  the  liver  and  the  groove  for 
ligamentum venosum on the posterior surface. Thus the anatomical right lobe includes the 
quadrate lobe on the inferior surface and caudate lobe on the posterior surface.
From the surgical point of view the more important one is the functional right and left lobes 
of the liver, the dividing line pass through the gall bladder bed anteriorly and inferiorly and 
through the groove for the inferior vena cava posteriorly. This functional division is based on 
the territory of arterial supply, venous and biliary drainage. Thus the caudate and quadrate 
lobes belong to the functional left lobe of the liver.
HEPATIC DUCTS
One hepatic duct each from the functional right and left lobes of the liver emerge and join 
together about 1-2 cms. below the porta hepatis to form the common hepatic duct. The left 
hepatic duct is always a single channel but on the right side, two separate ducts may exist in 
about 25% of cases, which join the left hepatic duct independently.
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COMMON HEPATIC DUCT
It is formed by the union of the two hepatic ducts and measure about 2-4 cms in length with 
an average inner diameter of 8 mm. It lies in the free border of the lesser omentum to the right 
and front of portal vein, with hepatic artery lying on its left side. The right branch of hepatic 
artery passes behind the common hepatic duct.
GALL BLADDER
The gall bladder is a pear shaped sac of about 7 cms in length with a capacity of about 30-50 
ml. which lies in the gall bladder fossa in the under surface of the liver. It has a fundus, body, 
infundibulum and a neck. The gall bladder is covered with peritoneum on all sides except at 
the place where it is in direct contact with the liver. The wall of the neck where it becomes the 
cystic duct may show a small diverticulum directed downwards and backwards. This pouch is 
called the Hartmann’s Pouch.
CYSTIC DUCT
It is the continuation of the neck of the gall bladder, and is about 4 cms long with an inner 
diameter of 2-3 mm. It passes up and to the left to join the common hepatic duct about 1-2 cm 
above the duodenum. The cystic artery commonly lies behind the cystic duct, it has spirally 
placed mucosal folds called Valve of Heister.
COMMON BILE DUCT
It measures about 7-8 cm long and consists of 4 parts. They are:
1. Supraduodenal 2.5 cm
2. Retroduodenal 2.5 cm
3. Paraduodenal/Intrahepatic 2.5 cm
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4. Intraduodenal Very small
PANCREAS
Pancreas is  a retroperitoneal  elongated gland lying between the C loop of duodenum and 
splenic hilum. It has a head, body and tail with a small constricted part between head and 
body  called  the  neck  and  another  small  downward  projection  from  the  head  called  the 
Uncinate Process. The main ductal system of the pancreas, the Duct of Wirsung, starts from 
the tail lying near the posterior than the anterior surface with small ducts of the lobes draining 
to it at right angles forming a herring bone pattern. It traverses the body and on reaching the 
neck it binds down posteriorly to join  with the common bile duct to form a common dilated 
hepatico pancreatic Ampulla of Vater surrounded by the Sphincter of Oddi which prevents the 
reflux of bile into the pancreas and vice versa.
LYMPHATIC DRAINAGE
LIVER
Lymphatics from the liver go to different nodes. They are:
1. Hepatic nodes seen in the lesser omentum along the hepatic artery and bile duct.
2. Nodes along the inferior vena cava above and below the diaphragm.
GALL BLADDER
1. directly to the liver
2. to the hepatic nodes in lesser omentum
3. from the left side of gall baldder to the node in the Calot’s Triangle.
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EXTRA HEPATIC BILIARY TREE
From this region the lymphatic drainage is to hepatic nodes along the lesser omentum and to 
the node in the Calot’s Triangle.
NERVE SUPPLY
The hepatobiliary tree gets nerve fibers from both parasympathetic (motor) and sympathetic 
(sensory) through vagus.
PHYSIOLOGY OF EXTRAHEPATIC BILIARY TREE
The primary function of extrahepatic  biliary tree is to transport  bile from the liver to the 
duodenum. Secondary function is to concentrate and modify the composition of bile.
TRANSPORT OF BILE
In animals with gall bladder, an organ which concentrates and stores bile, the flow of bile into 
duodenum does not parallel  its secretion by liver.  Between meals the ampullary sphincter 
offers certain degree of resistance to bile flow and hepatic bile enters the relaxed gall bladder 
and rest leaks into the duodenum.
The secretion pressure of bile in normal individual is 125 – 250 mm of water. This pressure is 
responsible for bile flow. The pressure in the biliary tree should be lower than the hepatic 
secretary pressure for maintaining the bile flow and it is usually 100-150 mm of water. The 
difference in pressure within the biliary passage and liver can be considered to be due to 
1. The activity of Sphincter of Oddi
2. The filling of gall bladder
3. The resorptive activity of gall bladder
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PHYSIOLOGY OF SPHINCTER OF ODDI
The sphincter  maintains  a  brisk peristaltic  motion  and basic  sphincter  rhythm consists  of 
opening and closing. The upper segment relaxes and opens and the ampulla gets filled up. The 
lower part of the sphincter then opens and bile flows into duodenum. 
Studies, which recorded sphincter of Oddi functions by indirect methods, such as observing 
the rate of inflow of fluid into the common bile duct, concluded that the sphincter of Oddi 
remains closed during fasting, thus diverting bile flow into the gall bladder. After a meal the 
sphincter is relaxed and bile flow from the common bile duct into the duodenum is propelled 
by pressure generated by the gall bladder.
FILLING AND EMPTYING OF GALL BLADDER
Filling of gall bladder occurs when it is empty and its intraluminal pressure drops to 11-14cm 
of water. Evacuation of gall bladder occurs when the gall bladder musculature contracts and 
intra luminal pressure mounts upto 200-300 mm of water.
These  functions  are  partly  under  the  parasympathetic  nervous  control  and  largely  under 
hormonal control by CCK.
RESORPTIVE ACTIVITY OF GALL BLADDER
The gall bladder mucosa reabsorbs the water and electrolytes entering it leaving behind bile 
salts, bile pigments and cholesterol. The active transport of sodium chloride and bicarbonate 
and obligatory water transport from bile to blood across the gall bladder mucosa results in 
concentration of bile.
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CHAPTER III
REVIEW OF LITERATURE – II 
JAUNDICE
The term ‘Jaundice’ is derived from the French word meaning ‘Yellow’ and refers to the 
presence of an excess of bile pigments in the tissues and the serum. It is a presenting sign of a 
number of hepatic and non-hepatic diseases. The differential diagnosis and management are 
dependent upon a appreciation of normal and abnormal variants of bile pigment metabolism.
PATHOPHYSIOLOGICAL CLASSIFICATION OF JAUNDICE
I. PREDOMINANTLY UNCONJUGATED HYPERBILIRUBINEMIA
A. Excess production of bilirubin
1. Hemolytic anaemia
2. Resorption of blood from large internal hemorrhages
3. Ineffective erythropoiesis
B. Reduced hepatic uptake
1. Drug induced
2. Prolonged fasting
3. Sepsis
C. Impaired bilirubin conjugation
1. Gilbert’s Syndrome
2. Criggler-Najjar Syndrome I & II
3. Physiological jaundice of new born
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4. Diffuse hepatocellular disease (hepatitis, cirrhosis)
II. PREDOMINANTLY CONJUGATED HYPERBILIRUBINEMIA (CHOLESTATIC 
JAUNDICE)
A. Decreased intrahepatic excretion of bilirubin
1. Dubin Johnson Syndrome
2. Rotor’s Syndrome
3. Drug induced
4. Hepatocellular disease (viral hepatitis)
5. Primary biliary cirrhosis
6. Sclerosing Cholangitis
B. Extrahepatic biliary obstruction
1. CBD stones
2. Carcinoma of the head of pancreas, extrahepatic hile ducts and ampulla of Vater
3. Extrahepatic biliary atresia
NORMAL BILE PIGMENT METABOLISM
The bile pigment – bilirubin is a tetra pyrrole, which is formed to the greatest extent from 
hemoglobin and to a lesser extent from myoglobin breakdown and hepatic synthesis itself. 
When the red blood cell is destroyed by the reticuloendothelial system the iron and globin are 
removed and the heme ring is opened and transformed into biliverdin, which is green. The 
later is reduced to become bilirubin, which is yellow. The bilirubin combines with albumin to 
form a relatively stable protein-pigment complex and is transported as such to the hepatic 
parenchymal cell.  This complex which is referred to as indirect reacting bilirubin, since it 
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gives the Vanderbergh diazo reaction only after treatment with alcohol and other substance 
that split the protein, is poorly soluble in water and is not excreted in the urine.
In the hepatic parenchymal cell the albumin is removed and the bilirubin is conjugated with 
glucuronic acid to form diglucuronide, which is water soluble and is excreted into the biliary 
canaliculi.  This substance  gives  an immediate  diazo  reaction  and hence termed as direct-
reacting. This is passed into urine. Normally there is less than 1.2 mg of direct reacting serum 
bilirubin and less than 0.3 mg of indirect reacting bilirubin per 100 ml of serum. 
The conjugated bilirubin which is excreted via the bile into the intestine is acted upon by 
bacteria  and  undergoes  a  series  of  reduction  leading  to  the  formation  of  two  groups  of 
compounds namely the colourless urobilinogen and coloured Stercobilin. The normal daily 
fecal  excretion  ranges  between  40  and  300 mg  with  an  average  of  100-200 mg,  and  in 
newborn infants because of the absence of bacterial  flora urobilinogen may be absent.  A 
reduction in the enteric bacteria is also responsible for the reduced pigment excretion that 
accompanies the use of intestinal antibiotics. Some of the urobilinogen is reabsorbed by way 
of portal venous system and returns to the liver, where it is either removed or to a small extent 
excreted in urine.
ABNORMAL BILE PIGMENT METABOLISM
No classification  is  totally  satisfactory.  The  classification  most  widely  used  distinguishes 
between hemolytic, obstructive and hepatocellular jaundice. However, it is most reasonable to 
categorize as
1. Those disease states in which the bile flow is unimpeded.
2. Those types that are associated with an impairment of the bile flow.
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NORMAL BILE EXCRETION
The overproduction of bile pigment from excessive hemolysis  creates a situation in which 
normal  liver  is  confronted  with  more  pigment  than  it  is  able  to  remove.  This  occurs  in 
physiological jaundice of infancy and all pathological hemolytic states. However the reserve 
capacity of the liver is great and even when the bilirubin production is increased six times 
there is only a 2-3 mg rise in the serum bilirubin level per dL of serum. In this situation the 
increase  in  serum bilirubin  is  in  the unocnjugated  indirect  reacting  bilirubin,  no bilirubin 
appears in the urine but there is an increase in the fecal and urinary urobilinogen. An excess 
of bilirubin production also occurs in shunt hyperbilirubinemia in which indirect  bilirubin 
accumulates in the absence of any reduction in red cell life span.
Constitutional  defects  of  liver  function  may  also  cause  hyperbilirubinemia  without 
impairment of bile flow. In Gilbert’s disease there is defect in the bilirubin transport into the 
liver cell, while in Criggler-Najjar syndrome the defect is an inability of liver to conjugate the 
bilirubin with glucuronic acid. In these states, the elevation of bile pigments is in the indirect 
reacting fraction. All other hepatic function tests are normal, and no histological abnormality 
is  noted.  With  all  of  the  above  mentioned  diseases  the  bilirubin  pigment  is  attached  to 
albumin and cannot be excreted by the kidney, thus prompting the term acholuric jaundice.
IMPAIRED BILE EXCRETION
All other diseases are associated with an accumulation of conjugated bilirubin in the blood 
and impaired excretion. The bilirubin pigment which is water soluble, is readily excreted into 
the urine, which becomes brown. The obstruction may be intrahepatic or extrahepatic.
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INTRAHEPATIC OBSTRUCTIVE JAUNDICE
In the Dubin-Johnson Syndrome, which is associated with the appearance of iron free pigment 
in the hepatic cells and normal liver function, the hepatic excretion of conjugated bilirubin is 
impaired.  Intrahepatic  cholestasis  has  also  been  related  to  a  variety  of  drugs  and 
hepatocellular disease. Methyltestosterone and norethiandrolene damage the microvilli of the 
bile canaliculi and may cause jaundice. The phenothiazine drugs such as chlorpromazine may 
evoke a hypersensitivity reaction in a small percentage of patients and result in cholangitic 
hepatitis and intrahepatic cholestasis. A lesion along the excretory pathway within the liver is 
believed to cause obstructive jaundice associated with primary biliary cirrhosis.
EXTRAHEPATIC CHOLESTASIS
This  is  caused by anatomical  obstruction  to  flow of  bile  from liver  to  the intestine.  The 
obstacle may be situated anywhere from the junction of right and left hepatic ducts to the 
termination  of  common bile  duct  in  the  duodenum.  Atresia,  stricture,  choledocholithiasis, 
tumours  of bile  duct  and pancreas,  choledochal  cysts  and parasites  have been implicated. 
Obstruction  of  extrahepatic  duct  results  in  an  increase  in  serum bilirubin  particularly  the 
direct reacting type, the appearance of bile in the urine and passage of clay coloured stools. 
When total  bilirubin  level  is  above 3 mg/dL,  the increase  in both the direct  and indirect 
reacting fraction parallel  one another.  With complete and persistant obstruction the serum 
bilirubin may plateau. In the fluctuating obstruction levels will change.
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EFFECTS OF BILIARY TRACT OBSTRUCTION
PHYSICAL EFFECTS
The normal  secretary pressure of bile  is  120-250 mm of water.  Following total  bile  duct 
obstruction, bile secretion will continue until CBD pressure rises to 170-220 mm of water 
after  which  secretion  decreases.  Cholesterol  and  phopholipid  secretion  is  more  readily 
reduced by high pressure than bile salt secretion making bile less lithogenic.
Complete obstruction of main extrahepatic bile duct of major segmental duct will normally 
lead to proximal dilatation. The lack of intrahepatic dilatation may be due to seconday hepatic 
fibrosis of co-existing alcoholic cirrhosis.
PAIN
Painless progressive jaundice is the classical hallmark of malignant biliary tract obstruction. 
But it is not uncommon to elicit a history of abdominal pain in these patients, the cause of 
pain being distention of gall bladder and bile duct or associated stretching of liver capsule in 
rapidly progressive obstruction.
PATHOLOGICAL CHANGES
BILE DUCTS AND CANALICULI
In biliary obstruction the canaliculi become dilated and microvilli distorted and swollen. Bile 
pigment thrombi may be seen in canaliculi and adjacent hepatocytes. In prolonged cholestasis, 
the canaliculi increase in length and tortuosity. Resorption of bile constituents from ductules 
leads to marked inflammatory reaction in the portal tracts with polymorphonuclear leucocyte 
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infiltrate. The hepatocyte of periportal zone shows disruption and eventually leading on to 
piecemeal  necrosis.  Experimental  evidence  shows that  if  obstruction  is  relieved  within  2 
weeks morphological changes are reversible.
CHOLANGITIS
Although the neutrophil  associated with cholangitis  is a chemical  reaction associated with 
biliary obstruction and does not imply bacterial inflammation, in presence of biliary stasis, 
secondary bacterial colonization may produce the additional element of infective cholangitis 
although classically referred to as ascending cholangitis the actual mechanism for entry of 
bacteria into the unoperated biliary tract may not always be clear. Studies by McPherson et al 
(1982)  showed  that  organisms  are  found  in  bile  in  approximately  1/3rd of  patients  with 
malignant biliary enteric anastamosis this rate may be higher. In another study Jackaman et al 
(1980)  found  that  highest  rate  of  biliary  colonization  were  found  in  patients  with 
choledocholithiasis  and benign  bile  duct  strictures  where  as  may as  80% of  patients  had 
positive cultures.
ATROPHY
The characteristic effect of unilateral hepatic duct obstruction is atrophy of obstructed liver 
parenchyma  with  compensatory  hyperplasia  of  unaffected  segments  of  liver.  A  grossly 
hypertrophied left lobe palpable in association with unilateral obstruction may not produce 
sufficient hyperbilirubinemia in presence of normal contralateral lobe.
The practical importance of lobar atrophy in a surgical context lies in the fact that an atrophic 
liver lobe may be inadequate to support life following the resection of normal or hyperplastic 
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liver tissue and biliary drainage of such an obstructed lobe may also fail to produce resolution 
of jaundice.
BIOCHEMICAL EFFECTS
BILIRUBIN
Conjugated hyperbilirubinemia is the classical biochemical feature of obstructive jaundice. 
But prolonged partial obstruction with functional effects on hepatocytes may produce a mixed 
biochemical picture with elevated circulating unconjugated bilirubin.
ALKALINE PHOSPHATASE
Elevation of this enzyme is the most widely used and probably the most sensitive indicator. It 
may  be  the  only  biochemical  indicator  of  incomplete  of  segmental  obstruction.  Acute 
obstruction  of  bile  duct  causes  regurgitation  of  enzyme  from  biliary  compartment  and 
increase in hepatic synthesis.
PROTEIN SYNTHESIS
Liver  occupies  a  central  role  in  protein  synthesis  and  quantitatively  albumin  is  the  most 
important  protein  synthesized  by  liver.  However  due  to  its  long  half  life  (20  days)  only 
minimal changes occur to hepatocyte damage. Nonetheless the frequent association of biliary 
obstruction with malignancy and malnutrition causes hypoalbuminemia.
An active marker of hepatic protein synthesis, serum prealbumin is more valuable since it has 
half life of only 1.9 days. The most important aspect of protein synthesis relates to synthesis 
of coagulation factors II, VII, IX & X and its failure is due to failure to absorb vit K due to 
absence of bile salts from intestine.
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LIPIDS
Cholesterol level may be elevated in biliary tract obstruction. A number of alterations in low 
density lipoproteins have been observed which are of no major functional importance.
CARBOHYDRATE METABOLISM
Abnormal glucose tolerance may be seen in patients with impaired liver function. But the 
malignant disease causing obstruction might be primary cause.
BILE SALT CIRCULATION
The  enterohepatic  circulation  of  bile  salts  is  completely  interrupted  by  total  biliary 
obstruction. This may lead to gross elevation of serum bile acid levels. This has two important 
metabolic consequences. Firstly,  due to the absence of bile salts in the intestine the small 
bowel microflora gets altered. Secondly, following external biliary drainage, the secretion of 
bile is under altered physiological drive.
ENDOTOXEMIA & RETICULOENDOTHELIAL FUNCTION
Endotoxin  is  a  lipopolysaccharide  derived  from the  cell  walls  of  gram negative  bacteria 
present in the gut. Normally only minute quantities of endotoxin enters the portal circulation 
and these traces are cleared by hepatic reticuloendothelial system. In obstructive jaundice the 
absence  of  bile  salts  from  intestine  causes  increased  formation  of  endotoxin  by  altered 
microflora  and  decreased  clearance  of  absorbed  endotoxin  due  to  depressed 
reticuloendothelial cell function resulting in endotoxemia in more than 50% of patients. The 
bile salt absorption is also quiet fast in biliary obstruction probably due to increased vascular 
permeability.  The  circulating  endotoxin  causes  pathological  effects  like  renal 
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vasoconstriction,  redistribution  of  intrarenal  blood  flow  and  activation  of  complement, 
leukocytes and platelets.
CHANGES AFTER RELIEF OF OBSTRUCTION
BILE SECRETION
Postoperative  study of  biliary secretion  is  done by the  insertion  of  external  percutaneous 
transhepatic drain. There is frequently a prompt and major cholestasis and bile volumes may 
exceed 4 liters per day. Failure to replace large volumes of fluid and electrolyte losses may 
result in dehydration and electrolyte depletion with a metabolic acidosis. The replacement of 
bile salts if desired may also be undertaken in the form of commercially available preparation.
During the first few days of biliary drainage the bile produced is of low bilirubin and bile salt 
concentration. This may be partly due to a slow return of impaired liver to normal function 
and also to loss of enterohepatic circulation of bile salts.
RECOVERY OF FUNCTION
In  majority  of  case plasma bilirubin  begins  to  fall  promptly after  insertion  of  a  drainage 
catheter  or  an  internal  biliary  bypass  procedure  and  this  is  accompanied  by  clinical 
improvement. However, return of hepatocyte function is not instantaneous.
Assessment  of  liver  function  by  serial  antipyrene  clearance  measurement  after  relief  of 
obstruction has shown that it takes about 6 weeks for it to return to normal values.
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STRUCTURAL CHANGES
The  reversal  of  structural  changes  in  liver  and  biliary  tract  following  decompression  of 
obstruction  is  variable.  Bile  ducts  which  have  beeen  subjected  to  edema,  inflammatory 
infiltration, cholangitis, and fibrotic changes are likely to retain some rigidity for considerable 
time after decompression.
As regards reversal of intra hepatic fibrotic changes following drainage it is difficult to obtain 
clear evidence since this would rely upon serial liver biopsies in asymptomatic patients so 
long as fibrotic changes remain short of true secondary biliary cirrhosis, they are reversible by 
adequate drainage. Even the portal hypertension secondary to such fibrosis may be improved 
with such drainage.
CLINICAL FEATURES
SYMPTOMS
Typically a patient with obstructive jaundice presents with dark urine, pale stools and pruritus 
of  varying  severity.  Information  regarding  initial  onset  and  whether  clinical  course  is 
intermittent and associated with pain, fever and rigors must be short. Attack precipitated by 
fat intake can be relevant. An episode of cholangitis is recognized if jaundice is associated 
with pain, rigor and pyrexia. Jaundice without significant pain or pain radiating to back may 
indicate  pancreatic  pathology.  However  this  is  not certain  and patients  with gallstones an 
present with back pain whereas patients with extensive carcinoma of head of pancreas may 
present with typical history of biliary colic.
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A fluctuating depth of jaundice is suggestive of intermittent obstruction as in periampullary 
carcinoma or temporary alteration of stone in the ampulla of vater. It is very rare in pancreatic 
cancer and cholangiocarcinoma. Weight loss, anorexia and pallor suggest malignancy of short 
duration. When these symptoms occur with painless jaundice, neoplasm of head of pancreas 
is likely. Pruritis may be present in all forms of jaundice and may either be progressive or 
fluctuate in intensity.
PHYSICAL EXAMINATION
GENERAL INSPECTION
The common stigmata of liver disease should be looked for – they are all indications of liver 
dysfunction. Jaundice is due to staining of tissues with bilirubin and possibly other pigments 
such as biliverdin. It is initially noticed in sclera. As jaundice progresses the skin becomes 
progressively  more  pigmented,  spider  naevi,  which  are  vascular  skin  lesions  supplied  by 
central  arteriole  is  occluded  with  a  pinhead.  Spider  naevi  usually  occur  in  the  region  of 
superior vena cava – chest above the level of nipple, face, neck and arms. Palmar erythema is 
obvious  and  pronounced  reddish  flushing  of  palms.  It  particularly  affects  the  thenar  and 
hypothenar eminence and bases of fingers.  Spontaneous bruising, echymosis and bleeding 
around  venipuncture  sites  are  well  recognized  signs  of  liver  disease  occurring  due  to 
abnormality in coagulation mechanisms. Long standing pruritis causing scratch marks all over 
the body can also be noted.
EXAMINATION OF LIVER
Palpation  of liver  should be combined with percussion to  determine  the  upper  and lower 
borders. The upper border of liver normally extends upto 5th intercostals space. Auscultation 
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over the liver may give some evidence of underlying disease. An arterial bruit is evidence of 
hepatocellular carcinoma and venous hum in portal hypertension.
SPLENIC ENLARGEMENT
Splenomegaly  can  be  detected  by  palpation  commencing  in  the  right  iliac  fossa  and 
progressing towards the left hypochondrium. Splenic notch can sometimes be recognized on 
the anterior border of grossly enlarged spleen.
ASCITIS
Clinical confirmation of ascitis is achieved by eliciting shifting dullness on percussion or fluid 
thrill on palpating the flanks. Ascitis could be due to hypoalbuminemia of liver dysfunction, 
portal hypertension or manifestation of advanced malignancy either of liver or pancreas.
GALL BLADDER SIGNS
The finding of a palpable  gall  bladder in the presence of features of obstructive jaundice 
suggests malignant obstruction of the biliary tree (Courvoisier’s Law). However failure to 
palpate gall bladder does not exclude the presence of malignant biliary obstruction. On the 
other hand it is possible to have a palpable gall bladder in the presence of gallstones where 
one stone obstructs the common bile duct and another is impacted in the Hartmann’s pouch or 
cystic  duct  resulting  in  an  empyema  or  mucocele  of  the  gall  bladder.  An  intermittently 
palpable gall bladder is suggestive of periampullary carcinoma.
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EVIDENCE OF PORTAL HYPERTENSION
Portal hypertension is usually associated with hepatosplenomegaly and ascitis. Large dilated 
abdominal  wall  veins  occur  due  to  collateral  circulation  between  the  portal  system  and 
systemic veins.
DIFFERENTIAL DIAGNOSIS IN CHOLESTASIS
I. EXTRAHEPATIC CAUSES
1. STONES
a) gallstones slipping into CBD
b) gallstone in cystic duct and getting impacted onto CBD (Mirrizi syndrome)
c) pancreatic calculus obstructing at the ampulla of Vater
2. STRICTURES
a) malignant carcinoma of CBD
b) Benign – surgical trauma
c) primary sclerosing cholangitis
3. TUMOURS OF THE BILIARY TREE
a) periampullary carcinoma
b) carcinoma of head of pancreas
c) cholangiocarcinoma
4. EXTRINSIC PRESSURE ON EXTRAHEPATIC BILIARY TRACT
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a) Metastatic lymphnodes near the biliary tract by pressure and later  by infiltration 
produce obstruction to biliary passages
b) primary lymphnodular disease involving the lymphnodes near biliary pathways – 
histiocytic non-Hodgkin’s lymphoma
c) Metastatic involvement of the connective tissue of hepatic hilum causing extrinsic 
compression on bile ducts
5. MISCELLANEOUS CAUSES
a) parasitic occlusion of CBD – Schistosomiasis
b) Mycotic condition
c) Choledochal cysts
d) Hepatic artery aneurysm
II. INTRAHEPATIC CAUSES
1. INTRAHEPATIC STONE
2. INTRAHEPATIC BILIARY STRICTURES
3. KLATSKIN’S TUMOUR
4. BILIARY DYSPLASIA
a) Congenital hepatic fibrosis
b) Cystic disease of the liver
c) Caroli’s disease
5. CONGENITAL AND INFANTILE ATRESIA OF BILE DUCTS
6. ANEURYSM OF BRANCHES OF HEPATIC ARTERY
7. CYSTS OF THE LIVER
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a) congenital
b) parasitic
8. PRIMARY AND SECONDARY MALIGNANCIES OF THE LIVER
CLINICAL  CLASSIFICATION  OF  OBSTRUCTIVE  BILIARY  TRACT 
DISEASE
Classification  proposed  by  Benjamin  (1983)  has  proved  useful  in  clinical  practice.  It 
recognizes four types of biliary obstruction. They are:
TYPE I: COMPLETE
Obstructive – producing progressive jaundice
Eg.: 
a) Tumours of head of pancreas
b) Cholangiocarcinoma
c) Ligation of CBD
d) Parenchymal damage to liver
TYPE II: INTERMITTENT
Obstruction which produces symptoms and biochemical changes with or without jaundice
Eg.:
a) choledocholithiasis
b) periampullary carcinoma
c) duodenal diverticula
d) papillomas of bile duct
e) choledochal cysts
f) polycystic liver disease
g) intrabiliary parasite
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TYPE III: CHRONIC INCOMPLETE
Obstruction  with  or  without  symptoms  and  biochemical  changes  eventually  producing 
pathological changes in bile ducts of liver
Eg.:
a) strictues of CBD
1) congenital
2) traumatic
3) post irradiation
b) stenosed biliary enteric anastamosis
c) stenosis of sphincter of Oddi
d) chronic pancreatitis
e) cystic fibrosis
TYPE IV: SEGMENTAL
Obstruction in which one or more anatomical segments of biliary tree may be obstructed. This 
in turn may be complete, intermittent or chronic incomplete.
Eg.:
a) traumatic (including iatrogenic)
b) hepatico choledocholithiasis
c) sclerosing cholangitis
d) cholangio carcinoma
INVESTIGATIONS
BIOCHEMISTRY
Biochemical features of cholestasis are:
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1. Conjugated hyperbilirubinemia
2. Elevation of alkaline phosphatase, 5’ nucleotidase,  gamma glutamyl transpeptidase. 
Th eenzyme 5’ nucleotidase is the most reliable since its level is not influenced by 
bone disease or alcoholism.
3. Minimal or no elevation of serum transaminases
4. Presence of bilirubin in the urine as conjugated bilirubin, which is water soluble and 
hence filtered by glomeruli
5. Elevation in serum cholesterol and bile acid levels although these are not routinely 
measured inpatients with cholestasis jaundice.
IMAGING TECHNIQUES
PLAIN ABDOMINAL AND CHEST SKIAGRAM
Calcification in the region of gall bladder indicates gall stone. Multiple areas of calcification 
in the region of the pancreas are helpful in diagnosing chronic calcific pancreatitis.
ULTRASONOGRAM
This  is  non-invasive  and  quick  to  perform,  but  requires  experience  in  technique  and 
interpretation. Extrahepatic biliary obstruction can be diagnosed by demonstration of dilated 
biliary radicals.  In experienced hands the accuracy in diagnosing ductal  dilatation is  over 
95%. In most iof the cases the cause of biliary obstruction can be traced by ultrasonogram. 
Enlargement  of  head  of  pancreas  is  suggestive  of  carcinoma.  Difficulties  in  achieving  a 
definite diagnosis arises principally with small lesions at the lower end of common bile duct 
and  which  is  often  obscured  by  gas  in  the  duodenum or  colon.  As  it  does  not  involve 
radiation, it can be used safely in pregnancy.
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ERCP – Ca. Pancreas 
causing 
MRCP – Ca. Ampulla of Vater
CT - Ca. Tail of the Pancreas
ENDOSCOPIC RETROGRADE CHOLANGIO-PANCREATICOGRAPHY (ERCP)
Upper GI endoscopy with a forward or oblique viewing pan endoscope should be performed 
in  jaundiced  patients  as  significant  gastrointestinal  pathology  is  encountered  in  25%  of 
jaundiced patients. This is indicated when obstructing agent is lower down in the CBD. This 
is  also  ideal  when ducts  are  not  dilated  or  visualization  of  pancreatic  duct  or  ampulla  is 
required. It permits concomitant endoscopic examination and biopsy of lesions encountered 
during  endoscopic  examination.  Certain  lesions  can  be  treated  or  palliated  during  this 
procedure like endoscopic stone removal, endoscopic nasobiliary drainage and stent insertion 
for inoperable malignant large bile duct obstruction. ERCP has very low morbidity due to 
pancreatitis (1%) and very low mortality (0.1%).
PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAM (PTC)
This  is  done by injecting  the  contrast  material  into  the  dilated  biliary  radicles  through a 
cannula. This more useful when the obstruction is higher up in the bile or hepatic ducts. 
CT findings in pancreatic carcinoma are:
a) Focal mass
b) Pancreatic atrophy/pancreatitis
c) CBD/PD dilatation
d) Vascular enhancement or displacement
e) Regional lymphadenopathy
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MAGNETIC RESONANCE CHOLANGIO-PANCREATICOGRAPHY (MRCP)
It  is  a newer development  in MRI. It  provides multiplanar,  cross-sectional,  reconstructive 
image  of  pancreaticobiliary  tree.  It  is  purely  diagnostic  with  no  therapeutic  intervention 
possible.  It  offers advantage over dynamic  CT in suspected hilar  cholangiocarcinoma and 
primary  gall  bladder  carcinoma.  Studies  show  promises  with  choledocholithiasis  and 
malignant bile duct obstruction.
ENDOSCOPIC ULTRASONOGRAPHY
It  is  in  the  early  stage  of  development.  A  useful  modality  for  tumour  exclusion  when 
transabdominal utrasonography or CT has failed and high index of suspicion of carcinoma 
exists  due to elevated tumour markers,  prior to elevated tumour markers or ERCP. It can 
confirm tumour of 1.2 cm in head of pancreas.
LAPAROSCOPY
Should be routinely used by surgeons in all patients with jaundice. It gives direct visualization 
of underlying pathology and is valuable in staging hepatobiliary and pancreatic tumours. It 
avoids unnecessary laparotomy for patients with inoperable diseases.
ANGIOGRAPHY
Preoperative angiography is indicated in 
1. history of previous major upper abdominal surgeries
2. doubtful resection on clinical and CT appearances
3. when it is anticipated to remove major vascular structures
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Angiographic findings in pancreatic carcinoma are:
1. parenchymal hypovascularity
2. angulation of vessels
3. encasement of vessels (arterial/venous)
4. displacement of vessels
5. arterial neovascularity
FINE NEEDLE ASPIRATION CYTOLOGY
A  fine  needle  of  21-23G  is  passed  under  guidance.  The  specimen  is  expressed  on  to 
microscopic  side,  smeared,  fixed  in  95%  alcohol  or  autospray  and  stained  by  modified 
papanicolaou  or  other  methods.  Diagnosis  can  be  made  within  20  minutes  of  obtaining 
FNAC. Irregularly arranged clusters of cells exhibiting cellular pleomorphism, large vesicular 
nuclei  and  prominent  nucleoli  are  seen.  However  such  cytological  appearances  may 
sometimes fail  to  differentiate  between adenocarcinoma of gland and lymphoma.  Positive 
diagnosis can be obtained in 87-100% with few false positive results.
The earlier  the tumour,  the smaller  it  is.  It  then becomes  difficult  to obtain diagnosis  by 
needle biopsy techniques. Complete resection remains the best biopsy. Every surgeon should 
be prepared to accept occasional benign biopsy report. This technique should be avoided in 
potentially respectable tumours with the theoretical possibility of seeding along needle tracks. 
It is to be noted that it could be on the other hand a very valuable method in elderly frail 
patients in whom a surgical palliation is being contemplated. It should also be avoided in a 
young  relatively  fit  patient  in  whom  a  histological  as  opposed  to  cytological  proof  is 
mandatory prior to chemo or radiotherapy. The sensitivity ranges from 33-84%.
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CARCINOMA OF PANCREAS
It includes carcinoma of the head proper and periampullary region. Almost all carcinoma of 
pancreas arise from the ductal  epithelium. Only 1% arises from acini.  The average age of 
patient is about 60 years, but carcinoma of ampulla the average age is about 5 years less. 
Males are more affected.
PATHOGENESIS
Incidence of carcinoma of the pancreas has risen steadily over the past 10 years. There are 
some factors, which can be considered as initiating or provoking carcinoma of pancreas. They 
are:
1. Cigarette smoking
2. Consumption of coffee
3. Diet rich in fat
4. Chemicals such as beta napthylamine and benzidine
5. Diabetes
6. Carcinogens in duodenal contents refluxing into the pancreatic duct
7. Alcohol consumption
PATHOLOGY
Adenocarcinoma is the predominant lesion often accompanied by extreme fibrous connective 
tissue stromal proliferation. The tumours may be mucinous of non-mucin secreting. Only 10% 
assume an adenosquamous pattern of extreme anaplasia with giant cell formation, numerous 
mitosis and bizarre pleomorphism. Only 5% arise in cyst and are termed cystadenocarcinoma.
37
Carcinomas of the ampulla of Vater are columnar cell adenocarcinoma. This neoplasm arises 
in duodenal papilla, in the ampulla of Vater or in the duodenal mucosa adjacent to the papilla 
there may be an area of pancreatitis in the head of pancreas. The primary lesion is so small 
that it is difficult to palpate. In such carcinoma, jaundice may not be progressive as recurrent 
sloughing  of  the  central  portion  of  the  tumour  will  relieve  obstruction  of  bile  duct  and 
jaundice becomes intermittent.
CLINICAL FEATURES
Carcinoma of the head of the pancreas usually presents with painless progressive obstructive 
jaundice. Progressive jaundice is usually associated with pruritis due to to the presence of bile 
salts in blood. The jaundice usually progresses steadily until the patient is almost green in 
colour. In case of periampullary carcinoma, the jaundice may be intermittent. Pain is not a 
marked feature. Patient may complain of dull and aching pain in the epigastrium. Pain is often 
relieved by sitting in  hunched position  and is  aggravated  by supine  position.  Eating may 
aggravate  pain.  Weight  loss  is  the  single  most  common  symptom  of  carcinoma  of  the 
pancreas irrespective of the position of the tumour. Diarrhea with pale and foul smelling stool 
is sometimes a feature of periampullary carcinoma. There may be steatorrhoea due to enzyme 
deficiency.
On examination, jaundice is the main sign. A palpable distended gall bladder is detected in 
60% of cases. Enlargement of liver is found in slightly more than half the cases. In carcinoma 
of head of pancreas it is often due to biliary obstruction.
Carcinoma  of  ampulla  of  Vater  shows  a  few peculiar  symptoms  and  signs.  Pain  is  less 
frequent in this condition but when present is apt to be more colicky in nature. Jaundice is 
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intermittent. Chills and fever are not uncommon due to associated cholangitis. Hematemesis 
and melena occasionally occurs in late cases as a result of direct invasion of duodenal or 
gastric  mucosa  by  tumour  and  portal  hypertension  secondary  to  splenic  or  portal  vein 
compression by the tumour.
CHOLANGIOCARCINOMA
The reported autopsy incidence of malignant bile duct tumour ranges from 0.01-0.5%. There 
is slight preponderance of male (1.5:1). The age at presentation varies but the peak incidence 
is in sixth decade. The etiology of bile duct cancer is unknown. Cholangiocarcinoma is seen 
with increasing frequency in parasitic infestation of biliary tree, cystic disease of biliary tract, 
chronic typhoid carriers, and ulcerative colitis and sclerosing cholangitis.
PATHOLOGY
Tumours are best classified into the anatomical site of origin
1. Intrahepatic tumour from minor hepatic ducts
2. Proximal from right or left hepatic ducts, cystic duct and it confluence with CBD.
3. Middle from the distal common hepatic duct, cystic and its confluence with CBD.
4. Distal from the distal common bile duct and periampullary region.
Tumours  of  the  minor  hepatic  ducts  are  often  diffuse  (multicentric)  and  difficult  to 
differentiate  from  primary  hepatocellular  carcinoma.  The  gross  appearance  of 
cholangiocarcinoma assumes one of the three forms. They are:
1. Strictures
2. Nodular
3. Papillary
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The majority of tumours are adenocarcinoma of varying origin. All cholangiocarcinomas have 
a special predilection for perineural spread and do not metastasise beyond the liver. The best 
prognosis is encountered after resection especially of distal and periampullary lesions.
CLINICAL FEATURES
The  main  presentation  (90%)  is  with  obstructive  jaundice  which  is  progressive  and 
accompanied by itching and anorexia.  Dull  upper abdominal  pain is a frequent  symptom. 
Some patients present acutely with cholangitis. Physical examination reveals hepatomegaly. 
Anemia is present in patients with papillary tumours especially at the lower end of bile duct 
and periampullary region. It is caused by chronic blood loss. The feces of these patients have 
a characteristic silvery appearance due to combination of steatorrhoea and altered blood. A 
palpable gall bladder is present in patients with distal tumours.
PRE-OPERATIVE PREPARATION
1. All jaundiced patients must be kept in a good state of nutrition and hydration with 
supplemental  intravenous  fluids,  elemental  diet  and  multivitamins  as  deemed 
necessary. Renal failure due to hypovolemia is a tremendous hazard post-operatively 
and  a  continuous  diuresis  is  maintained  at  all  times.  If  the  patient  is  grossly 
malnourished, a period of parenteral hyperalimentation both before and after operation 
may be of additional benefit.
2. Blood  clotting  deficiencies  must  be  corrected.  Anaemia  is  corrected  by  blood 
transfusions. Daily injection of Vit K is administered,  preferably 4-5 days prior to 
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operation. Six units of fresh frozen plasma, six units of platelets and atleast six units of 
blood should be made available in operating room.
3. Cardiopulmonary function should be assessed by pulmonary function tests, chest X-
ray  and  ECG.  Smoking  is  prohibited.  Intensive  pulmonary  physiotherapy,  active 
mobilization and leg exercises are strongly encouraged post operatively.
4. Antibiotic prophylaxis should be given since there is impaired wound healing due to 
depressed immune function.
5. Nutritional status to be assessed and supported as there is impaired wound healing due 
to decreased fibroblastic activity and general protein and calorie malnutrition.
6. If patient is critically ill with one or more of the following parameters,
a) highly elevated serum bilirubin (>12 mg%)
b) sepsis
c) hepatorenal failure
d) severe cardiopulmonary disease
e) malnutrition
a percutaneous transhepatic biliary drainage or endoscopic decompression should be 
attempted to tide over the patient for 2-3 weeks before major surgery. If the technique 
of  percutaneous  biliary  drainage  or  endoscopic  stenting  is  not  available,  a  simple 
cholecystectomy or T-tube drainage of CBD may be undertaken.
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TREATMENT OF MALIGNANT OBSTRUCTIVE JAUNDICE
Treatment can be either
1. Curative
2. Palliative
CURATIVE TREATMENT
Surgery  is  now  considered  as  the  gold  standard  for  treatment  of  malignant  obstructive 
jaundice  against  which  all  other  new  modalities  are  considered.  Halsted  performed  first 
curative and successful resection of periampullary carcinoma at  John Hopkins Hospital  in 
1898. He performed local resection of ampullary tumour.  Presently standard resection for 
periampullary carcinoma and head of pancreas tumours involves a pancreaticoduodenectomy, 
first performed successfully by Kausch in 1909 and popularized by Whipple 1935. The gall 
bladder,  CBD,  entire  duodenum,  head  of  pancreas,  pancreas  upto  the  level  of  superior 
mesenteric  vein,  pylorus  and  distal  stomach  are  resected.  Restoration  of  gastrointestinal 
continuity utilizes the proximal jejunum, brought out through the transverse mesocolon for 
pancreaticojejunostomy, hepaticojejunostomy and gastrojejunostomy. The standard Whipple 
resection remains the classic thrrapy for these tumours and can be successfully performed in 
experienced hand swith mortality less than 5%. A modification of standard Whipple resection, 
the pylorus preserving pancreaticoduodenectomy has gained popularity in recent years. This 
modification  eliminates  gastric  resection  and  leaves  a  2cm cuff  of  duodenum for  enteric 
reconstruction as duodenojejunostomy.
PALLIATIVE SURGERY
Palliative  surgery for  periampullary  carcinoma  is  performed  in  patients  with  unresectable 
disease discovered at the time of laparatomy or in patients with prohibitive risk for resectional 
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therapy  (advanced  age,  limited  cardiopulmonary  reserve  and  also  poorly  alleviated  non-
operatively).
1. Relief of jaundice, pruritis and impending cholangitis: Biliary tract decompression can 
be  done  either  by  cholecystojejunostomy  or  by  hepaticojejunostomy  (each  with 
diverting enterostomy) depending on whether the cystic duct is widely patent and is in 
full communication with the biliary tree proximal to the obstructing cancer.
2. Relief of duodenal obstruction: If the patient lives for more than few months, duodenal 
obstruction usually occurs. It is therefore advisable to perform a gastrojejunostomy at 
the primary operation.
NON OPERATIVE MANAGEMENT
When a patient is unfit or refuses surgery an alternative method of palliation of the jaundice is 
by endoscopic sphincterotomy and placement of biliary stent. This approach does not relieve 
any additional obstruction,  which may be present. If patient survives for more than a few 
months,  recurrent cholangitis  associated with stent blockage is a problem that necessitates 
regular endoscopic removal and replacement of the stent.
Percutaneous  transhepatic  placement  of  internal  expandable  metal  stent  is  being  tried  by 
inteventional radiologist and offers yet another option for palliation of the jaundiced patient 
with malignant biliary tract obstruction.
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Rooftop Incision
Exposure of the Abdominal Cavity
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Gastro-Jejunostomy in progress
Choledocho-Jejunostomy in progress
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Pancreatico-Jejunostomy in progress
Resected Specimen
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TREATMENT OF CHOLANGIOCARCINOMA
Resection is the best method of treatment and is indicated for all  operative tumours in fit 
individuals. The reported respectable rate varies but averages 20%. The benefits of resection 
are:
1. The possibility of cure or long term survival especially for distal bile duct tumours
2. Resection provides the best form of palliation in terms of duration and freedom from 
infective complications.
The  surgical  procedure  depends  on  the  location  of  tumour.  For  hilar  lesions,  an  anterior 
segmentectomy IV provides good access to confluence, allowing good clearance proximal to 
the tumour and facilitates hepaticojejunostomy. When the tumour extends along the right or 
left duct with extension to respective lobe, the resection includes a lobectomy in continuation 
with main tumour mass. Middle tumours are excised from just below the confluence down to 
the duodenum together with associated pericholedochal lymphnodes. The surgical treatment 
of periampullary tumours is pancreaticoduodenectomy. The results of hepatic transplantation 
for cholangiocarcinoma (diffuse intrahepatic type) have been disappointing.
PALLIATIVE SURGERY
If tumour is inoperable,  a bilio-enteric bypass is performed. Anastamosis of Roux loop to 
segment III duct using the round ligament approach gives the best results for inoperable hilar 
lesions. Longmire operation in which anastamosis of the segment III duct to Roux loop of 
jejunum after  left lateral  segmentectomy and Smith operation used to be done earlier,  but 
there is no added advantage to these procedures. A cholecystojejunostomy is performed for 
inoperable distal tumours. A gastrojejunostomy is added if duodenal obstruction is present or 
considered imminent in patient with periampullary tumour.
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NON OPERATIVE MANAGEMENT
In patients who are considered inoperable as preoperative assessment and those who are too 
old and frail, palliation of jaundice is achieved by percutaneous transhepatic or endoscopic 
stenting.  The  endoprosthesis  has  to  be  large  8-10  FG and may  require  replacement  if  it 
becomes  blocked.  Recently  self-expandable  stainless  steel  wire  endoprosthesis  have  been 
introduced  in  management  of  patients  with  malignant  biliary  strictures.  Other  causes  of 
malignant  obstructive  jaundice  are  due  to  extrinsic  compression  on  the  biliary  tract  by 
tumours, Metastatic lymphnodes near the biliary tract by pressure and later by infiltration and 
primary lymphonodular disease involving lymph nodes near biliary pathways. Treatment is 
primarily to relieve obstructive jaundice and troublesome pruritis and steatorrhoea.
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CHAPTER IV
AIM OF STUDY
1. To analyze the incidence of causes of malignant obstructive jaundice in our hospital.
2. To analyze the age and sex distribution.
3. To study various clinical presentations.
4. To evaluate various management modalities.
5. To analyze complications associated with obstructive jaundice.
6. To evaluate the histopathology of resected specimen.
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CHAPTER V
MATERIALS AND METHODS
DESIGN
This is a prospective descriptive study. Study population has been selected after necessary 
exclusion criteria have been applied.
SETTING
The study is done at a tertiary care centre namely, Govt. Rajaji Hospital, Madurai in various 
General Surgery units and the Dept. of Surgical Gastroenterology. The period of study is from 
June 2006 to November 2008.
POPULATION / PARTICIPANTS / SAMPLE SIZE
A random selection of 50 patients admitted in surgical wards within June 2006 to Nov 2008 
has been done.
INCLUSION CRITERIA
1. Patients with malignancies of hepatobiliary system or pancreas producing obstructive 
jaundice
2. Patients  with  malignancy  outside  the  hepatobiliary  system  or  pancreas  producing 
infiltration of biliary tree or secondaries in porta hepatis.
EXCLUSION CRITERIA
1. Patients with benign causes of obstructive jaundice.
2. Patients with hemolytic and hepatocellular jaundice.
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CHAPTER VI
PROFORMA
Name :
Age :
Sex :
Address :
IP Number :
Unit :
Date of Admission :
Date of Surgery :
Date of Discharge/Death :
Duration of illness :
Symptoms : Weight loss, diarrhea, jaundice, bleeding per 
rectum, melena, abdominal pain, anorexia, 
steatorrhoea, dark urine, constipation, 
belching, vomiting, hematemesis, abdominal 
distention, pruritis
Signs : Icterus, hepatomegaly, palpable gall bladder, 
tenderness, ascitis, palpable spleen, abdominal 
mass, supraclavicular nodes and lymphnodes
Past History : Chronic calcific pancreatitis, diabetes mellitus, 
previous surgery
Personal History : Exposure to chemical carcinogen, alcohol, 
tobacco, coffee, dietary habits
Family History : Pancreatic, bowel or other malignancies
Lab Investigations : USG, CT scan, ERCP/PTC, Angiography, 
liver function tests, RBS, BUN, serum 
creatinine
Assessment of Surgical Risk :
Preoperative Decompression Procedures :
Surgical Procedure : Exploratory laparotomy, drainage, palliative 
resection and curative resection
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Blood Transfusion given :
Per-Op Findings :
Metastasis : Regional lymphnodes, liver, peritoneum and 
other sites
Post-Op Complications :
Histopathological Report :
Mean Hospital Stay :
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CHAPTER VII
RESULTS OF ANALYSIS
A total of 50 cases of malignant obstructive jaundice were included in the study. These cases 
were admitted in the Govt. Rajaji Hospital, Madurai between June 2006 and November 2008. 
Going through the statistics it is found that there are a substantial number of patients with 
malignant obstructive jaundice.
Out of the 50 patients studied in detail there were 31 males and 19 females. Age analysis of 
these cases showed that maximum incidence is between 41-50 age group.
Out of the 50 patients, 15 were diabetic patients whose diabetic status was kept under control 
with varying measures from adjustment of diet to insulin administration. 15 patients gave a 
past history of jaundice.
In  our  study,  jaundice  and  dark  coloured  urine  was  complained  by  almost  all  patients 
followed by anorexia and weight loss. A palpable gall bladder was complained in 29 patients. 
Presentation with mass and ascitis are common when compared to western studies.
Among the malignancies causing obstructive jaundice carcinoma of head of pancreas is the 
commonest cause, followed by periampullary carcinoma, cholangiocarcinoma and carcinoma 
of the gall  bladder.  Other miscellaneous causes include secondaries at  porta  hepatis  from 
stomach and gastrointestinal tract and also malignancies producing extrinsic compression of 
bile duct.
53
Of various risk factors in pancreatic carcinogenesis, we have made an in depth analysis of 
tumours of pancreas with chronic calcific pancreatitis. The relationship with familial chronic 
pancreatitis (FCP) is now well documented (Comfort and Steinberg, 1952) and was found to 
be seen in 1/3rd of patients developing pancreatic cancer. Castleman et al in 1972 stated that 
first degree relatives of patients with familial  calcific pancreatitis  run an increased risk of 
cancer even without chronic pancreatitis. In our study, the risk rate was 24%.
Operative  procedures  done  for  patients  with  malignant  obstructive  jaundice  are  many. 
Cholecystojejunostomy and gastrojejunostomy leads the list with 29 patients undergoing the 
procedure.  Classical  Whipple’s resection was done in 10 patients  and modified Whipple’s 
resection in 4 patients. One patient was subjected to Choledochojejunostomy since cystic duct 
insertion  was  very  low  and  there  was  dilated  CBD.  Segment  III  bypass  and 
hepaticojejunostomy were done in three patients  with Klatskin’s tumour.  In 4 patients  no 
palliative surgeries were possible and only stenting was done. No surgical intervention was 
done in 3 patients as they refused surgery and due to poor general condition.
When laparatomy was performed, it  was found that regional lymphnodes were affected in 
majority  (76.5%)  followed  by  liver  metastasis  and  peritoneal  deposits.  Very  few  had 
metastasis to pelvic regions, lungs and brain.
Complications  following Whipple’s procedure were low. There were 4 cases of fistula,  2 
cases of pancreatitis and 2 cases of wound infection. Two patients died in the post-operative 
period (mortality within 30 days of surgery). One patient died due to myocardial infarction 
and one patient due to life threatening infection and cholangitis.
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In four cases of obstructive jaundice due to extension of growth from stomach into the region 
of terminal CBD, cholecystojejunostomy with gastrojejunostomy was possible for palliation 
of jaundice and duodenal obstruction. The remaining 2 cases had infiltration from the growth 
upto porta hepatic where no decompression was attempted.
None of the common hepatic duct or common bile duct growths were resectable due to local 
infiltration to the vital vasculature around porta hepatis. Out of 9 cases with such growths, 
four were treated with placement of stent through the growth into the dilated intrahepatic 
biliary tree.
In 5 cases of carcinoma of gall bladder, the growths were very advanced with infiltration of 
hepatic  ducts  and  metastasis  in  liver.  Two patients  were  treated  with  placement  of  stent 
through the growth into the dilated biliary tree. And in other three patients no surgery was 
possible.
Wound infection was reported in 9 patients followed by cholangitis in 6 patients, which was 
treated by antibiotics and removal of collection and proper stressing. There were 6 cases of 
delayed gastric emptying which were treated with nasogastric suction.
There were 8 deaths in this group. Most of the patients died due to the threatening cholangitis 
and renal failure.
Histopathology reports of patients subjected to Whipple’s resection showed most of them to 
be  moderately  and  poorly  differentiated  adenocarcinoma.  There  was  well  differentiated 
histology in only 5 cases.
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CHAPTER VIIII
DISCUSSION OF ANALYSIS
Surgery for obstructive jaundice is fascinating because of wide variety of etiological factors, 
varying number of surgical methods and technical challenges in reaching pancreas and biliary 
tree.
The observation that many of the patients  were diabetic  show they stand a higher risk of 
development  of  pancreatic  malignancy.  The  study  of  relationship  of  chronic  calcific 
pancreatitis  patients  with  carcinoma  of  pancreas  is  well  documented  in  1/3rd of  patients 
developing pancreatic  cancer.  Castleman et  al  in 1972 stated that first  degree relatives  of 
patients with familial calcific pancreatitis run an increased risk of cancer even without chronic 
pancreatitis. In our study the risk rate was 22.5%.
Whether to go for a radical surgical procedure like Whipple’s resection or choose a simple 
bypass procedure in cases of malignant lesions of pancreas producing obstructive jaundice is 
highly  debatable.  The  hospital  mortality  for  pancreaticoduodenectomy  has  decreased 
substantially  and  long  term  survival  has  improved  significantly.  In  mid  1990 
pancreaticoduodenectomy can  be  performed  at  regional  referral  centres  with  an  operative 
mortality of 1-2%. Five year survival between 20-30% for patients with resected pancreatic 
cancer. Recent data suggests that quality of survival is better with standard operations and 
best  with  pylorus  preserving  pancreaticoduodenectomy  (PPPD).  However  debate  will 
continue.
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In  1993  Geer  and  Brennan  reported  130  patients  undergoing  standard 
pancreaticoduodenectomy with actual survival rate of 21%. In John Hopkins hospital,  201 
patients  undergoing  pancreaticoduodenectomy showed actual  5-year  survival  rate  as  21%. 
This study also demonstrates that  survival  has improved from decade to decade.  In sharp 
contrast the Mayo clinic group reports a hospital mortality of 3% and a 5-year survival rate of 
6.8%.
The factors which appear to influence survival include negative resection margins, tumour 
diameter  more  than  5  cm,  DNA content  measured  by  image  cytometry.  In  patients  with 
Hopkins series in whom the DNA content was diploid, 5 year survival was 39% and when 
tumour was aneuploid, 5 year survival was only 8%. Lymphnode status is an important factor 
that has bearing on prognosis. In series from Hopkins 144 patients were node positive and 5-
year  survival  in  this  group  was  14%.  Thus  positive  lymphnodes  is  clearly  a  negative 
prognostic finding. Prognostic predictive values of other factors have been arrived at in yet 
another  study  in  univariate  but  not  in  multivariate  analysis.  These  include  histological 
differentiation, gender of patient, operative time and number of blood transfusions. Survival 
following pancreaticoduodenectomy has improved over the past several decades. There are 
multiple  reasons  for  this.  Between  1970  and  1980,  a  decrease  in  the  number  of  blood 
transfusions clearly played a contributory role. Positive resection margins were common in 
1970s than 1980s and 1990s and this played an important role. Of late from these records it is 
evident  that  Whipple’s  resection  is  a  better  form of surgical  treatment  atleast  in  cases of 
periampullary carcinoma in experienced hands.
Treatment of cholangiocarcinoma, especially hilar carcinomas are disappointing. The place of 
resection for attempted cure of patients with tumour at confluence of bile duct is strongly 
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debated.  Thus  Longmire  was  able  to  resect  only  6  of  33  lesions  and  tumour  excision 
combined with hepatic resection. Similarly Smith (1981) treated 33 cases in 33 years and 
excised  only 5.  in  none there  was  hepatic  resection.  Longmire  (1973)  in  anatomical  and 
clinical study recognized that involvement of vessels was the limiting factor to resection in 
many instances. Risk of drainage operation in treatment of biliary tract obstruction is high 
with  mortality  of  20%  or  more.  Indeed  even  nonoperative  endoscopic  or  percutaneous 
intubation  methods  for  the  relief  of  obstructive  jaundice  are  associated  with  significant 
morbidity and 30 day mortality of 20%. Majority of patients with cholangiocarcinoma will 
not be suitable for resection and may be ill or old or have concomitant disease. The option 
open in the management are either no treatment at all or some form of biliary decompression 
either by means of biliary enteric anastamosis or by one of trans-tumoural tube allowing relief 
of biliary obstruction. Alterative methods of tubal drainage (such as placement of transhepatic 
endoprosthesis  or  percutaneous  transhepatic  drainage).  They  have  potential  for  serious 
infection and or PTBD 30 day mortality of atleast 20% is reported. Evander and colleagues in 
a  series  of  53  patients  subjected  40  to  some  form  of  biliary  drainage,  majority  by 
percutaneous transhepatic technique. The median survival was only 2.5 months. It is clear that 
results  of nonoperative techniques  for biliary decompression in biliary cancer  have yet  to 
show improvement  over  surgical  approach.  However  with  liberal  use  of  round  ligament 
approach 28 patients were operated on with mortality of 2.1%. Recent experiences in France 
(Bismuth  1988) reveal  a good quality  palliation  with operable  mortality of only 7%. The 
results are better than those achieved by nonsurgical methods.
In 7 cases of cholangiocarcinoma in our study, treatment was disappointing – only 3 (4.8%) 
were  subjected  to  segment  III  bypass  and  4  patients  were  palliated  with  transtumoural 
stenting. No operative or palliative procedures were attempted in 3 patients.
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CHAPTER IX
SUMMARY AND CONCLUSION
1. There is a significant increase in the incidence of malignant obstructive jaundice
2. Majority of tumours are in the head of pancreas (54%)
3. The maximum of age incidence is between 41 and 50 years (50%)
4. Male : Female ratio is 3:2
5. Resectability rate was 20.8% with 10 patients undergoing Whipple’s resection or its 
modifications
6. Chronic calcific pancreatitis is a premalignant condition
7. A 26% incidence of CCP with carcinoma of head of pancreas was noted.
8. 100% of patients complained jaundice, weight loss and anorexia.
9. A palpable gall bladder was noted in 58% of the cases compared to 30-35% reported 
in western literature.
10. A palliative Cholecystojejunostomy with gastrojejunostomy tops the list of operative 
procedures
11. Mortality  due  to  palliative  procedures  was  7%  and  morbidity  patterns  of  wound 
infection is 9.2%, cholangitis is 5% and delayed gastric emptying is 6%.
12. Median hospital stay for palliative procedures was 21 days.
13. Mortality rate following Whipple’s procedure was 7.8%
14. Only palliative procedures are possible in Klatskin’s tumour like segments III bypass 
(4.2%) and transtumoural stenting (6.2%)
15. Moderately  differentiated  adenocarcninoma  was  the  histology  in  40%,  poorly 
differentiated adenocarcinoma 30% and well differentiated in 30%.
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CHAPTER X
TABLES AND CHARTS
Table 1. Age distribution of cases in study population
Age Group Number Percentage
31-40 5 10%
41-50 25 50%
51-60 12 24%
61-70 8 16%
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Table 2. Sex Distribution
Sex Number Percentage
Male 31 62%
Female 19 38%
SEX DISTRIBUTION
62%
38%
Male
Female
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Table 3. Tumour Types
Tumour types Number Percentage
Carcinoma of head of pancreas 27 54%
Periampullary Carcinoma 12 24%
Cholangiocarcinoma 5 10%
Carcinoma gall bladder 2 4%
Miscellaneous 4 8%
TUMOUR TYPES
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ma
Carcinoma gall
bladder
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Table 4. Relationship of carcinoma head of pancreas with chronic calcific pancreatitis
Carcinoma of head of pancreas Number Percentage
With chronic calficic pancreatitis 7 25.9%
Without chronic calcific pancreatitis 20 74.1%
RELATIONSHIP OF CA. HEAD OF 
PANCREAS WITH CCP
26%
74%
With chronic calficic
pancreatitis
Without chronic
calcific pancreatitis
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Table 5. Histopathological Grading of Tumours resected by Whipple’s Procedure
Histopathological Grading Number Percentage
Well differentiated 3 30%
Moderately differentiated 4 40%
Poorly differentiated 3 30%
HISTOPATHOLOGICAL GRADING
30%
40%
30%
Well differentiated
Moderately
differentiated
Poorly
differentiated
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MASTER CHART
Sl. 
No Name IP No. Age Sex
Clinical 
Features
Palp. 
GB
Ca. 
Type CCP Grading Surgery
Post-op 
Complication
Status at 
30 days
1 Selvakumar 452538 65 M J / DU / WL + PC – Palliative Uneventful Alive
2 Shanmugam 454460 54 M J / DU + HP + – Palliative DGE Alive
3 Kamatchi 462152 45 F J / DU /WL + M – NIL Uneventful Dead
4 Valarmathy 467817 57 F J / DU /WL + HP – – Palliative CI Alive
5 Velmurugan 475316 42 M J / DU + HP + – Palliative WI Alive
6 Ulaganathan 480613 65 M J / DU /WL – HP + – Palliative Uneventful Alive
7 Chinnathai 494261 46 F J / DU /WL + PC Well Diff. Whipple Pancreatitis Alive
8 Narayanan 74325 44 M J / DU – HP + – Palliative CI Dead
9 Muthulaxmi 76183 55 F J / DU – CC – Palliative WI Alive
10 Sethupandi 72505 45 M J / DU /WL – HP – – Palliative DGE Alive
11 Kattaiyan 77430 32 M J / DU /WL – CGB – Stenting Uneventful Dead
12 Vijaya 81952 47 F J / DU + PC – Palliative Uneventful Alive
13 Amsavalli 90017 47 F J / DU – HP + Poor Diff. Whipple WI Dead
14 Udaiyappan 119871 62 M J / DU /WL – HP – Poor Diff. Whipple Fistula Alive
15 Jayalaxmi 128392 42 F J / DU /WL + HP + – Palliative Uneventful Alive
16 Paramasivam 140599 57 M J / DU /WL + M – Stenting DGE Alive
17 Kandhasamy 183033 48 M J / DU /WL + PC – Palliative WI Alive
18 Laxmi 172923 45 F J / DU /WL + HP + Well Diff. Whipple Fistula Alive
19 JeyaShree 15018 43 F J / DU /WL – CC – Palliative CI Dead
20 Pavithra 16681 52 F J / DU – HP – – Palliative WI Alive
21 Sakthivel 17723 44 M J / DU + PC – Palliative Uneventful Alive
22 Rajendran 20275 49 M J / DU /WL + PC – NIL Uneventful Dead
23 Madasamy 21404 56 M J / DU /WL + HP + Mod. Diff. Whipple WI Alive
24 Ganesan 21948 34 M J / DU – PC – Palliative Uneventful Alive
25 Annalaxmi 33049 50 F J / DU + HP – – Palliative DGE Alive
26 Alamelu 58395 43 F J / DU /WL – CC – Palliative Uneventful Alive
27 Mohd. Ali 50339 58 M J / DU /WL – HP + Mod. Diff. Whipple Pancreatitis Alive
28 Rajangam 60438 46 M J / DU /WL + HP + – Palliative Uneventful Alive
29 Selvi 73938 70 F J / DU /WL + PC – Palliative CI Alive
30 Chinnasamy 93848 59 M J / DU – PC – Palliative Uneventful Alive
Sl.
No. Name IP No. Age Sex
Clinical 
Features
Palp. 
GB
Ca. 
Type CCP Grading Surgery
Post-op 
Complication
Status at 
30 days
31 Raman 101119 45 J / DU /WL – HP + Mod. Diff. Whipple Fistula Dead
32 Periyavalli 120397 47 F J / DU /WL – PC – Stenting Uneventful Alive
33 Mohd. Mathar 145940 55 M J / DU /WL – CC – Palliative WI Alive
34 Pattammal 194848 42 F J / DU /WL + HP – – NIL Uneventful Dead
35 Pushpam 19384 33 F J / DU /WL + CGB – Stenting DGE Alive
36 Ponnusamy 28437 65 M J / DU /WL + HP – Poor Diff. Whipple Uneventful Alive
37 Ramu 30940 54 M J / DU – HP + – Palliative CI Alive
38 Anandhavallli 31295 41 F J / DU + CC – Palliative Uneventful Alive
40 Krishnamoorthy 35096 61 M J / DU /WL + PC – Palliative WI Alive
41 Kanagaraj 40599 31 M J / DU /WL – M – Palliative Uneventful Alive
42 Antony 43050 43 M J / DU /WL + HP + Well Diff. Whipple Fistula Alive
43 Manikandan 46504 55 M J / DU /WL – HP + – Palliative Uneventful Alive
44 Savithri 44303 32 F J / DU + PC – Palliative Uneventful Alive
45 Rani 59303 45 F J / DU /WL + HP + Mod. Diff. Whipple Uneventful Alive
46 Stephenraj 58383 58 M J / DU /WL – M – Palliative CI Alive
47 Sivalingam 58493 65 M J / DU – HP + – Palliative WI Alive
48 Muthu 58695 45 M J / DU /WL + HP + – Stenting Uneventful Alive
49 Revathy 60283 47 F J / DU /WL + HP + – Palliative DGE Alive
50 Munisamy 61394 67 M J / DU /WL – HP + – Palliative Uneventful Alive
LEGEND:
J - Jaundice HP - Ca. Head of Pancreas WI - Wound Infection
WL - Weight Loss PC - Periampullary Carcinoma CI - Cholangitis
DU - Dark Urine CC - CholangioCarcinoma DGE - Delayed Gastric Emptying
CCP - Chronic Calcific Pancreatitis CGB - Ca. Gall Bladder
M - Miscellaneous
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